Your browser doesn't support javascript.
loading
A genome wide association study of Plasmodium falciparum susceptibility to 22 antimalarial drugs in Kenya.
Wendler, Jason P; Okombo, John; Amato, Roberto; Miotto, Olivo; Kiara, Steven M; Mwai, Leah; Pole, Lewa; O'Brien, John; Manske, Magnus; Alcock, Dan; Drury, Eleanor; Sanders, Mandy; Oyola, Samuel O; Malangone, Cinzia; Jyothi, Dushyanth; Miles, Alistair; Rockett, Kirk A; MacInnis, Bronwyn L; Marsh, Kevin; Bejon, Philip; Nzila, Alexis; Kwiatkowski, Dominic P.
Afiliação
  • Wendler JP; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Okombo J; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya.
  • Amato R; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Miotto O; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Hu
  • Kiara SM; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya.
  • Mwai L; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya.
  • Pole L; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya.
  • O'Brien J; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Manske M; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Alcock D; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Drury E; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Sanders M; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Oyola SO; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Malangone C; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Jyothi D; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Miles A; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • Rockett KA; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
  • MacInnis BL; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom.
  • Marsh K; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya.
  • Bejon P; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Kenya Medical Research Institute (KEMRI)/Wellcome Trust Collaborative Research Program, Kilifi, Kenya; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Ki
  • Nzila A; Department of Biology, King Fahd University of Petroleum and Minerals, Dhahran, Saudi Arabia.
  • Kwiatkowski DP; Medical Research Council (MRC) Centre for Genomics and Global Health, University of Oxford, Oxford, United Kingdom; Wellcome Trust Sanger Institute, Hinxton, Cambridge, United Kingdom; Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom.
PLoS One ; 9(5): e96486, 2014.
Article em En | MEDLINE | ID: mdl-24809681
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Resistência a Medicamentos / DNA de Protozoário / Polimorfismo de Nucleotídeo Único / Antimaláricos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plasmodium falciparum / Resistência a Medicamentos / DNA de Protozoário / Polimorfismo de Nucleotídeo Único / Antimaláricos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Child / Humans País/Região como assunto: Africa Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Estados Unidos